Mix Vaccine for Metastatic Kidney Cancer

Clinical trial NCT03357289 · COMPLETED

Trial details

NCT number: NCT03357289
Sponsor: Fuda Cancer Hospital, Guangzhou
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastasis From Malignant Tumor of Kidney (Disorder)Reaction - Mixed Vaccine

Start date: 2017-11-30
Primary completion: 2018-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.